Back

Long-term safety of stereotactic body radiotherapy for ablation of ventricular tachycardia: a multicentric study

2 September 2019 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: The substrate for ventricular arrhythmia - From ECG to non-invasive therapy Clinical ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Jakub Cvek

University Hospital Ostrava, Ostrava (Czechia)

4 More presentations in this session

Presentation thumbnail
State of the Art - Imaging for substrate identification in ventricular arrhythmia
Professor P. Jais (Neuilly sur Seine, FR)
Slides Video
Presentation thumbnail
Manifestations of myocardial fibrosis in the standard 12-lead electrocardiogram
Mr L. Holmstrom (Oulu, FI)
Abstract Slides Video
Presentation thumbnail
Characterization of the arrhythmogenic substrate with multimodality imaging in ischemic patients undergoing VT ablation: relationship between cardiac computed tomography and magnetic resonance
Doctor G. Zucchelli (Pisa, IT)
Abstract
Presentation thumbnail
Non-invasive therapy for ventricular arrhythmia.
Doctor D. Packer (Salt Lake City, US)
Slides Video

Access the full session

Session thumbnail
The substrate for ventricular arrhythmia - From ECG to non-invasive therapy

The Event

Event poster

ESC Congress 2019

2 September 2019 11:54 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines
thumbnail
Congress Session
Ventricular tachycardia ablation in challenging scenarios: case-based management strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources